Molecular Cross Talks FoxP3 with HDAC7&9 and FoxP3-HAT (p300) Underlying to Immune Suppression Activities of FoxP3 in Leprosy PatientsFriday, 13 September 2013 at 11:30 Add to Calendar ▼2013-09-13 11:30:002013-09-13 12:30:00Europe/LondonMolecular Cross Talks FoxP3 with HDAC7and9 and FoxP3-HAT (p300) Underlying to Immune Suppression Activities of FoxP3 in Leprosy PatientsPoint-of-Care Diagnostics World Congress 2013 in San Diego, CA, USASan Diego, CA, USASELECTBIOenquiries@selectbiosciences.com The present report envisages two important phenomenons from leprosy orifice 1) how does FoxP3 behave like potent transcription repression, 2) how does the expression of FoxP3 foster competitive fitness to T regs. |